Ascendis Pharma Other Current Liability (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

213.96 +5.20 (+2.49%) USD | NASDAQ | Jan 13, 10:57

View Other Current Liability (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Liability (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	Upgrade
Evaxion AS	--
DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade